1. REGULATION (EU) 2017/ 745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL - of 5 April 2017 - on medical devices, amending Directive 2001/ 83/ EC, Regulation (EC) No 178/ 2002 and Regulation (EC) No 1223/ 2009 and repealing Council Directives 90/ 385/ EEC and 93/ 42/ EEC. European Parliament and Council of the European Union (2017).
2. Use of International Standard ISO 10993-1, “Biological evaluation of medical devices-Part 1: Evaluation and testing within a risk management process” - Guidance for Industry and Food and Drug Administration Staff Preface Public Comment. U.S. Food & Drug Administration (2020). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-international-standard-iso-10993-1-biological-evaluation-medical-devices-part-1-evaluation-and [Accessed July 28, 2022]
3. ISO 10993-1:2018: Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process. International Organization for Standardization (2018).
4. Study of the in vitro cytotoxicity testing of medical devices
5. ISO 10993-5:2009: Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity. International Organization for Standardization (2009).